EPO and anemia (phenotype): Anemia is a common clinical condition in malignancy [1], which may result from blood loss [1], impaired erythropoiesis due to inadequate production or efficacy of erythropoietin [2, 3], decreased availability of iron [1, 4, 5] or from decreased life span of circulating erythrocytes [6].